ITCI vs. ADSK
Compare and contrast key facts about Intra-Cellular Therapies, Inc. (ITCI) and Autodesk, Inc. (ADSK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ITCI or ADSK.
Correlation
The correlation between ITCI and ADSK is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ITCI vs. ADSK - Performance Comparison
Key characteristics
ITCI:
1.39
ADSK:
0.43
ITCI:
3.27
ADSK:
0.74
ITCI:
1.40
ADSK:
1.10
ITCI:
4.00
ADSK:
0.28
ITCI:
8.62
ADSK:
1.22
ITCI:
8.64%
ADSK:
9.53%
ITCI:
53.73%
ADSK:
27.35%
ITCI:
-87.64%
ADSK:
-76.92%
ITCI:
0.00%
ADSK:
-16.73%
Fundamentals
ITCI:
$13.67B
ADSK:
$61.42B
ITCI:
-$0.87
ADSK:
$5.02
ITCI:
0.00
ADSK:
1.73
ITCI:
$481.41M
ADSK:
$4.49B
ITCI:
$444.86M
ADSK:
$4.05B
ITCI:
-$87.26M
ADSK:
$1.08B
Returns By Period
In the year-to-date period, ITCI achieves a 53.98% return, which is significantly higher than ADSK's -3.58% return. Over the past 10 years, ITCI has outperformed ADSK with an annualized return of 18.17%, while ADSK has yielded a comparatively lower 16.51% annualized return.
ITCI
53.98%
1.14%
72.66%
78.78%
39.20%
18.17%
ADSK
-3.58%
-5.46%
11.65%
10.90%
7.15%
16.51%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ITCI vs. ADSK — Risk-Adjusted Performance Rank
ITCI
ADSK
ITCI vs. ADSK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Intra-Cellular Therapies, Inc. (ITCI) and Autodesk, Inc. (ADSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ITCI vs. ADSK - Dividend Comparison
Neither ITCI nor ADSK has paid dividends to shareholders.
Drawdowns
ITCI vs. ADSK - Drawdown Comparison
The maximum ITCI drawdown since its inception was -87.64%, which is greater than ADSK's maximum drawdown of -76.92%. Use the drawdown chart below to compare losses from any high point for ITCI and ADSK. For additional features, visit the drawdowns tool.
Volatility
ITCI vs. ADSK - Volatility Comparison
The current volatility for Intra-Cellular Therapies, Inc. (ITCI) is 0.83%, while Autodesk, Inc. (ADSK) has a volatility of 7.81%. This indicates that ITCI experiences smaller price fluctuations and is considered to be less risky than ADSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ITCI vs. ADSK - Financials Comparison
This section allows you to compare key financial metrics between Intra-Cellular Therapies, Inc. and Autodesk, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities